Arcutis Biotherapeutics Director Halley E. Gilbert Receives Equity Awards

This Form 4 filing discloses equity awards granted to Halley E. Gilbert, a non-employee director of Arcutis Biotherapeutics, Inc. (ARQT). On June 5, 2026, Gilbert received 5,778 restricted stock units (RSUs) that will vest on the earlier of June 5, 2027 or immediately before the next annual stockholders meeting, subject to continued service. Additionally, Gilbert was granted stock options for 16,667 shares with an exercise price of $21.23 per share, expiring June 5, 2036, with the same vesting schedule. Following these transactions, Gilbert holds 27,901 shares of common stock directly and 16,667 stock options. The awards were granted in connection with Gilbert's service as a director at the company's 2026 annual meeting of stockholders.